These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6135591)

  • 1. Diazepam in tardive dyskinesia.
    Weber SS; Dufresne RL; Becker RE; Mastrati P
    Drug Intell Clin Pharm; 1983; 17(7-8):523-7. PubMed ID: 6135591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model.
    Singh MM; Becker RE; Pitman RK; Nasrallah HA; Lal H; Dufresne RL; Weber SS; McCalley-Whitters M
    Biol Psychiatry; 1982 Jun; 17(6):729-42. PubMed ID: 6125219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement in tardive dyskinesia after muscimol therapy.
    Tamminga CA; Crayton JW; Chase TN
    Arch Gen Psychiatry; 1979 May; 36(5):595-8. PubMed ID: 35117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepines for neuroleptic-induced tardive dyskinesia.
    Bhoopathi PS; Soares-Weiser K
    Cochrane Database Syst Rev; 2006 Jul; (3):CD000205. PubMed ID: 16855954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amantadine on tardive dyskinesia: a randomized, double-blind, placebo-controlled study.
    Pappa S; Tsouli S; Apostolou G; Mavreas V; Konitsiotis S
    Clin Neuropharmacol; 2010; 33(6):271-5. PubMed ID: 21121175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical effects of calcium-hopantenate on neuroleptics-induced tardive dyskinesia.
    Kashihara K; Ebara T; Yamamoto M; Ogawa T; Harada T; Otsuki S
    Folia Psychiatr Neurol Jpn; 1985; 39(2):147-53. PubMed ID: 2866149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V; Kaptsan A; Miodownik C; Kotler M
    Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of two benzodiazepines ("diazepam" versus "nitrazepam") in the treatment of postneuroleptic tardive dyskinesia.
    Sârbulescu A; Alexandrescu L; Georgescu MJ
    Neurol Psychiatr (Bucur); 1986; 24(3):189-93. PubMed ID: 2877486
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing antipsychotic-induced tardive dyskinesia.
    Gardos G
    Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is diltiazem effective in treating the symptoms of (tardive) dyskinesia in chronic psychiatric inpatients? A negative, double-blind, placebo-controlled trial.
    Loonen AJ; Verwey HA; Roels PR; van Bavel LP; Doorschot CH
    J Clin Psychopharmacol; 1992 Feb; 12(1):39-42. PubMed ID: 1348061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced tardive dyskinesia.
    Chan HY; Chiang SC; Chang CJ; Gau SS; Chen JJ; Chen CH; Hwu HG; Lai MS
    J Clin Psychiatry; 2010 Sep; 71(9):1226-33. PubMed ID: 20441726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
    Thaker GK; Tamminga CA; Alphs LD; Lafferman J; Ferraro TN; Hare TA
    Arch Gen Psychiatry; 1987 Jun; 44(6):522-9. PubMed ID: 3034188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tardive dyskinesia: clinical, biological, and pharmacological perspectives.
    Berger PA; Rexroth K
    Schizophr Bull; 1980; 6(1):102-16. PubMed ID: 6102788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic measures in tardive dyskinesia].
    Tegeler J; Wöller W
    Fortschr Neurol Psychiatr; 1983 Jun; 51(6):203-26. PubMed ID: 6136457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonazepam treatment of tardive dyskinesia: a practical GABAmimetic strategy.
    Thaker GK; Nguyen JA; Strauss ME; Jacobson R; Kaup BA; Tamminga CA
    Am J Psychiatry; 1990 Apr; 147(4):445-51. PubMed ID: 1969244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
    Suddath RL; Straw GM; Freed WJ; Bigelow LB; Kirch DG; Wyatt RJ
    Pharmacol Biochem Behav; 1991 Jul; 39(3):743-5. PubMed ID: 1686106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvement.
    Singh MM; Becker RE; Pitman RK; Nasrallah HA; Lal H
    Brain Res Bull; 1983 Aug; 11(2):179-85. PubMed ID: 6313141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.